Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

January 21, 2019

Farmington’s Bactana completes $1.3M funding round

Photo | Janine Gelineau/UConn Health The research space at UConn Health's Cell and Genome Sciences Building in Farmington.
By Joe Cooper

Farmington animal health biotech Bactana Corp. said it’s raised $1.3 million in convertible debt during its first-ever fundraising round.

Bactana, which develops microbes that increase the efficiency of raising food-producing animals like dairy and beef cattle, on Monday announced the closing of the investment round led by quasi-public Connecticut Innovations, Cornell University and several other funds and private investors.

The company said it will use the financing to expand its laboratory and facilities located at UConn Health’s Cell and Genome Sciences Building at 400 Farmington Ave.

Officials said the funds will also be used to trial its product, hire technical experts and develop commercial manufacturing capabilities before its product launch.

Sign up for Enews

Most Recent

Most Recent

Related Content

Thumbnail Lamont proposes new AI venture fund, creating 2 jobs at DECD to coordinate AI strategy
Thumbnail CT Innovations invests nearly $49M in early-stage companies in FY24
Thumbnail CT Innovations invested $12.6M in early-stage companies during first 3 months of 2024
Thumbnail Stamford’s Cara Therapeutics to merge with Houston biopharma firm

0 Comments

Order a PDF